
![]() | Read in Browser | |||||||||
![]() | ||||||||||
![]() | ||||||||||
![]() ![]() ![]() ![]() ![]() | ||||||||||
|
Refresher: OPEC+ abandoned talks last week that would have boosted oil supply in monthly installments from August after the UAE rejected the plans, insisting its current baseline was too low. OPEC+ has not yet made progress in resolving the dispute, making the prospect of another policy meeting this week less likely. Meanwhile, the IEA still anticipates global oil demand to rise by 5.4M barrels per day this year and by another 3M barrels in 2022, largely unchanged from last month's forecast.
"Although bullish sentiment has been somewhat tempered recently, oil prices are still comfortably holding above $70/bbl," said Stephen Brennock, oil analyst at PVM Oil Associates. "Whether this remains so depends wholly on the next move by the OPEC+ alliance." Brent crude futures (CO1:COM) rose another 0.8% to $75.75/bbl overnight, while U.S. WTI futures (CL1:COM) were ahead by 0.8% to $74.67/bbl.
Go deeper: Tensions between the UAE and OPEC leader Saudi Arabia - which controls a third of the group's total crude reserves - are going beyond oil. Over the past decade, the Saudis and Emiratis have coordinated on a number of major initiatives, like countering the Arab Spring, boycotting Qatar and establishing a sales tax across the Gulf Cooperation Council. However, the UAE has been flexing its own geopolitical aspirations, including withdrawing support for the Saudi military alliance in Yemen and the signing of the Abraham Accords with Israel. The Saudis have meanwhile called for foreign companies to move their regional headquarters to Riyadh (from Dubai) or risk lucrative government contracts, and following the OPEC impasse, the Kingdom moved to restrict citizens' travel to the UAE.
Gene editing offers to change our world in many profound ways, though there are grave risks associated with the medical technology. An expert panel from the World Health Organization met yesterday to strongly oppose the genetic modifications in humans that will pass on to future generations. The committee was established in late 2018 after a Chinese scientist claimed he had performed gene editing in twin babies in an attempt to give them protection against HIV.
Quote: "No-one in their right mind should contemplate doing it because the techniques are simply not safe enough or efficient enough and we're not ready in terms of looking at all the ethical considerations," said the panelist, Robin Lovell-Badge of Britain's Francis Crick Institute.
Late last month, Intellia Therapeutics (NTLA) took the biotech world by storm after the company posted positive early-stage trial results for its gene-editing candidate NTLA-2001 in a rare disease called transthyretin amyloidosis. Researchers injected a CRISPR drug directly into candidates' bloodstream and the editing technology was able to nearly shut off production of the toxic protein generated by their livers. With results indicating the efficacy and safety of in-vivo CRISPR genome editing for the first time in humans, companies relying on gene-editing technology surged in the following days.
Outlook: The expert panel from the WHO is also calling for a generous distribution of gene editing technologies to enable the poorer countries to benefit from the medical field that recently gained worldwide attention. It's also backing efforts to develop global standards on gene-editing, the establishment of an international registry of experiments and a way for whistleblowers to report their concerns. (11 comments)
In Europe, at midday, London +0.1%. Paris -0.2%. Frankfurt -0.1%.
Futures at 6:20, Dow -0.1%. S&P flat. Nasdaq +0.3%. Crude +0.8% at $74.67. Gold +0.1% at $1807.90. Bitcoin -2.3% at $33312.
Ten-year Treasury Yield unchanged 1.36%
8:30 Consumer Price Index
8:55 Redbook Chain Store Sales
12:00 PM Fed's Bostic Speech
12:45 PM Fed's Kashkari Speech
1:00 PM Results of $24B, 30-Year Note Auction
2:00PM Treasury Statement
2:30 PM Fed's Bostic Speech
2:50 PM Fed's Rosengren Speech
Companies reporting earnings today »
France to require health pass for bars, cafes, attractions and travel.
J&J (NYSE:JNJ) vaccine: FDA adds neurological disorder warning.
Israel approves third Pfizer (NYSE:PFE) shot for the immuno-compromised.
Reports... Broadcom (NASDAQ:AVGO) in talks over $15B-plus deal for SAS.
Tesla (NASDAQ:TSLA) rises after Musk testifies on SolarCity acquisition.
Former TikTok (BDNCE) CEO: Need higher return for Chinese investments.
Disney (NYSE:DIS) raises price of ESPN+ by a dollar to $6.99 per month.
Boeing (NYSE:BA) production problems? FAA mandates additional 787 fixes.
Lithium stocks catch fire; Albemarle (NYSE:ALB) rallies to new highs.


Like Wall Street Breakfast? Try our other newsletters as well.
This email was sent to you because you signed up to receive Wall Street Breakfast.
If you do not want to receive Wall Street Breakfast emails, click here to unsubscribe.
Sent by Seeking Alpha, 52 Vanderbilt Avenue, 13th floor, New York, NY 10017
EmoticonEmoticon